When Pitt announced last month that its researchers were working on a COVID-19 vaccine and seeing promising results, we held our collective breath. Some of us did celebratory handstands, others made GIFs or imagined the new, intolerable heights Pittsburgh pride might reach with a eureka moment in Oakland.
But weeks after the announcement, few of us know the names or faces of the people leading the charge. We know Jonas Salk, whose Pitt-made polio vaccine ended one of the deadliest epidemics in American history. And now wed like to introduce some of the people working to end this pandemic, which has claimed more than 245,000 lives worldwide in a matter of months.
At Pitt, work is primarily focused on two projects: A vaccine delivered via a fingertip-sized patch called a microneedle array vaccine and a measles vaccine thats been genetically modified to also target the novel coronavirus. (Thats the virus that causes the COVID-19 disease.)
These projects are two of the more than 175 vaccine candidates in various stages of development or testing around the world. And these are the people working to make another medical miracle possible in Pittsburgh.
Quotes have been provided by Pitt.
Title: Associate professor of surgery, Pitt School of Medicine
Hometown: Bari, Italy
Bio: Attended the Bari University School of Medicine and did a post-doctoral fellowship with the Department of Molecular Genetics and Biochemistry at Pitts School of Medicine. Gambotto has also worked on a Zika vaccine, a MERS vaccine, development of an Ebola vaccine, and more.
COVID-19 project: Microneedle Array Vaccine
How it works: A vaccine is delivered with a fingertip-sized patch containing 400 tiny needles. The patch goes on like a Band-Aid and then the needles which are made entirely of sugar and the protein pieces simply dissolve into the skin.
Why its promising: The vaccine was tested on mice and produced enough coronavirus antibodies to potentially neutralize the virus.
Where it stands: The researchers have applied for FDA approval to begin a human clinical trial in the coming months. UPMC spokesperson Erin Hare says the researchers are still negotiating with the FDA and that its hard to know exactly when that testing might start.
Quote: Thats why its important to fund vaccine research, Gambotto said. You never know where the next pandemic will come from.
Research team members: Eun Kim, Shaohua Huang, and Thomas W. Kenniston
Title: Professor and chair, Department of Dermatology at Pitts School of Medicine
Hometown: Greensburg
Bio: Attended Pitt and Harvard Medical School and did an internship at Massachusetts General Hospital in Boston and a fellowship at the Dana-Farber Cancer Institute, also in Boston. Falos career has focused on developing skin cancer immunotherapies, skin-targeted vaccines, treatments for skin aging, and more.
COVID-19 project: Microneedle Array Vaccine
Quote: Our ability to rapidly develop this vaccine was a result of scientists with expertise in diverse areas of research working together with a common goal.
Do microneedles hurt? We developed this to build on the original scratch method used to deliver the smallpox vaccine to the skin, Falo explained. And its actually pretty painless it feels kind of like Velcro.
Hurdles: The major challenges are how to take the vaccine we developed and improve upon it. Right now we dont know what the response will be in humans but we know there are multiple approaches we can take to make an even better vaccine in animals, and so we see this as an iterative process
Lab members: Geza Erdos, Stephen Balmert, Cara Carey, Emrullah Korkmaz, Nikita Patel, and Jiying Zhang
Titles: Director, Center for Vaccine Research at UPMC; Professor of Microbiology and Molecular Genetics, University of Pittsburgh
Hometown: Lurgan, Northern Ireland
Bio: Attended Queens University in Belfast and Boston University School of Medicine. Duprex said his Center for Vaccine Research at Pitt was quickly awarded funding to join the COVID-19 fight because of Pitts long history of working with viruses.
COVID-19 project: Measles Vector Vaccine
How it works: This method involves genetically modifying a measles vaccine to include coronavirus proteins, essentially piggybacking on a time-tested inoculation. The small amounts of weakened coronavirus do the same thing that small amounts of rubeola virus proteins (the cause of measles) do when injected into the body they jumpstart our immune response without causing a full-blown illness, priming our immune systems to recognize and combat the virus ahead of any future exposures.
Why its promising: The measles vaccine is commonplace and considered safe. Using it in this way speeds up development of a potential COVID-19 vaccine. The same has been done with vaccine attempts for Ebola, HIV-1, MERS, SARS, West Nile, Zika, and more.
X factor: Its unclear if a prior measles vaccination has any impact on the effectiveness of this measles-based COVID-19 vaccine. Hare said while that question will need to be addressed in testing, prior research indicates it wont be an issue.
Where it stands: Duprexs research team and their partners have made a candidate vaccine that theyre preparing for animal testing in Paris and Pittsburgh. But mass doses likely wouldnt be available for a year or more.
Quote: There are virologists all around the world who have been trained for this moment.
Lab members: Linda Murphy, Sham Nambulli, and Natasha Tilston-Lunel
Like stories like this? Support us bybecoming a memberorcontributing to our crowdfunding campaign.
By Colin Deppen
Go here to see the original:
Meet the Pitt researchers working to end the COVID-19 pandemic - The Incline
- 1st draft of a human 'pangenome' published, adding millions of ... - May 17th, 2023
- A Brief Guide to Genomics - National Human Genome Research Institute - May 17th, 2023
- Human genetics - Immunogenetics | Britannica - April 23rd, 2023
- A Troublesome Inheritance - Wikipedia - April 23rd, 2023
- Human - Simple English Wikipedia, the free encyclopedia - January 29th, 2023
- Human Genetics and Genomics Training Program - Hopkins Medicine - January 4th, 2023
- Genetics vs. Genomics Fact Sheet - Genome.gov - December 18th, 2022
- Human Genetics and Molecular Biology, PhD - Johns Hopkins University - December 18th, 2022
- Race (human categorization) - Wikipedia - December 2nd, 2022
- Human Y-chromosome DNA haplogroup - Wikipedia - November 24th, 2022
- Abstracts | International Congress of Human Genetics 2023 - November 24th, 2022
- Human genetic variation - Wikipedia - November 6th, 2022
- Genetics | The Smithsonian Institution's Human Origins Program - October 29th, 2022
- Fluent BioSciences showcasing breakthrough solutions to enable unprecedented scale, cost-efficiency and access for single-cell RNA sequencing at the... - October 29th, 2022
- Researchers seek to unravel the mystery of susceptibility to drug addiction - Newswise - October 4th, 2022
- NIH initiative to systematically investigate and establish function of every human gene - National Institutes of Health (.gov) - October 4th, 2022
- ANGPTL7, a therapeutic target for increased intraocular pressure and glaucoma | Communications Biology - Nature.com - October 4th, 2022
- Does obesity have more to do with the brain than we initially thought? - Medical News Today - October 4th, 2022
- Who will get the call from Stockholm? It's time for STAT's 2022 Nobel Prize predictions - STAT - October 4th, 2022
- Solving medical mysteries: Physicians and researchers collaborate to study the most challenging cases - AAMC - October 4th, 2022
- Mystery gene matures the skeleton of the cell - EurekAlert - October 4th, 2022
- What Is The Most Important factor Driving The Global Human Genetics Market? - PharmiWeb.com - September 25th, 2022
- How Africa's genetic diversity can be harnessed to close the continent's 'drug and treatment gap' - Genetic Literacy Project - September 25th, 2022
- Ability to move to the pulse of music has genetic link - DTNEXT - September 25th, 2022
- Is the Spike Protein Changing Our Gene Expression? - The Epoch Times - September 25th, 2022
- How prehistoric DNA is helping to unlock the secrets of human evolution - EL PAS USA - September 25th, 2022
- Personalised medicine and the advantages of big data and AI-based diagnostics - Medical Device Network - September 25th, 2022
- Viewpoint: In the post Roe v Wade world, what changes should a biology textbook writer make to address the medical repercussions of Dobbs? - Genetic... - September 25th, 2022
- Bears' ability to regulate insulin narrowed down to eight proteins WSU Insider - WSU News - September 25th, 2022
- Sex, Selection and Biodiversity - Syracuse.edu - Syracuse University - September 25th, 2022
- Was the Russian Flu the first coronavirus pandemic? Find out at next Science Caf - University of Nebraska at Kearney - September 25th, 2022
- University of Chicago South Side Science Fest created to show off the fun, myriad pathways into field. - Chicago Tribune - September 25th, 2022
- The genetics of human personality - PubMed - August 14th, 2022
- Genetics - The Harvey Institute for Human Genetics - GBMC HealthCare in ... - August 14th, 2022
- Degrees of the Future 2022: Genetics - Gizmodo - August 14th, 2022
- U of U Health-Led Research Awarded $28 Million to Explore HIV's Inner Workings and Vulnerabilities - University of Utah Health Care - August 14th, 2022
- Revisiting Companies That Had Their IPO in 2018 - Investment U - August 14th, 2022
- Monkeypox Myth Busting: Here's What You Need to Know - The Mighty - August 14th, 2022
- Relay Therapeutics Reports Second Quarter 2022 Financial Results and Corporate Highlights - Yahoo Finance - August 5th, 2022
- Baylor receives NCI grant to study liver cancer risk and prevention - Baylor College of Medicine News - August 5th, 2022
- Whole Exome Sequencing Market reach a valuation of US$ 4,256.30 Mn, at a CAGR of 19.24% in the Forecast 2030 - BioSpace - August 5th, 2022
- Mendels Genetic Revolution and the Legacy of Scientific Racism - NewsClick - August 5th, 2022
- AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH - BioSpace - August 5th, 2022
- Cotton Buds Market Value Is Estimated to Reach USD 747.16 BN By 2028, With 3.2% CAGR Credence Research - Digital Journal - August 5th, 2022
- Verve Therapeutics Shares Up 84%; ARKG Offers Exposure - ETFdb.com - July 27th, 2022
- Double up on the guac? Those avocados are good for your heart health - American Heart Association - July 27th, 2022
- Extending the PAX1 spectrum: a dominantly inherited variant causes oculo-auriculo-vertebral syndrome | European Journal of Human Genetics - Nature.com - July 27th, 2022
- Scientists Unravel the Mystery of Junk Genes That Are Key to Brain Development - SciTechDaily - July 27th, 2022
- COVID-19 Can Make the Brain Age by 2 Decades; Here's 1 Way to Reverse Aging - The Epoch Times - July 27th, 2022
- Mice Model Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Service, Technology, Indication, End User, Application, and Mode -... - July 27th, 2022
- Master's Degree in Human Genetics | Human Genetics | Michigan Medicine ... - July 11th, 2022
- Here's how the $100 Human Genome will Change Medicine - BioSpace - July 11th, 2022
- Genomic medicine: the role of the nursing workforce - Nursing Times - July 11th, 2022
- AbbVie Half Breaks Up with Alector on Alzheimer's - BioSpace - July 11th, 2022
- The human identification market size is projected to reach - GlobeNewswire - July 11th, 2022
- Global wheat production can be doubled to feed millions and save land, say scientists - Sky News - July 11th, 2022
- Huntsville native among TIMEs 100 most influential people - WHNT News 19 - July 3rd, 2022
- New hope for IVF patients as global study published in Human Reproduction shows AI can effectively assess genetic integrity of embryos - Yahoo Finance - July 3rd, 2022
- A Week At The Most Secretive Conference On Aging - Forbes - July 3rd, 2022
- Human genetics shape the gut microbiome - PMC - June 13th, 2022
- expert reaction to a conference abstract on retinal screening predicting risk of myocardial infarction - Science Media Centre - June 13th, 2022
- New Comprehensive Map Ties Every Human Gene to Its Function - SciTechDaily - June 13th, 2022
- Buffalo shooters manifesto quoted a university researcher. Thats raising questions about racism in academia - Yahoo News - June 13th, 2022
- Thalidomide could be used as a therapeutic for AVMs - Cosmos - June 13th, 2022
- How Electric Fish Were Able to Evolve Electric Organs - UT News - University of Texas - June 4th, 2022
- Survival of the Best: The Past, Present and Future of Plants - CSRwire.com - June 4th, 2022
- AMGEN ANNOUNCES WEBCAST OF 2022 JEFFERIES HEALTHCARE CONFERENCE | News | wfmz.com - 69News WFMZ-TV - June 4th, 2022
- Experts Discover New Disease Caused by Faulty Genes Affecting the Kidney and Liver: Newcastle University Study - Nature World News - June 4th, 2022
- At-Home Colorectal Cancer Testing and Follow-Up Vary by Ethnicity - Medscape - June 4th, 2022
- Who is your real parent? Our Father on Netflix depicts the dark side of 'secret serial sperm donation'. My birth has a similar origin but with a more... - June 4th, 2022
- Autism and the complete human genome: Q&A with Evan Eichler | Spectrum - Spectrum - May 15th, 2022
- Increased Mutations in Children Can Be Traced Back to Mistakes in Father's Sperm - Neuroscience News - May 15th, 2022
- Not All Is Rosy For The Pink Pigeon - Eurasia Review - May 15th, 2022
- Why haven't we cloned a human yet? - Livescience.com - May 15th, 2022
- Study probes the relationship between genetics, proteins, and disease risk - The Hub at Johns Hopkins - May 15th, 2022
- Singular Genomics Announces Formation of Scientific Advisory Board - BioSpace - May 15th, 2022
- COVID Resistance Might Be Tied To Genetics: Experts - Medical Daily - May 15th, 2022
- Letter: Why no to Roe and abortion - INFORUM - May 15th, 2022
- Gut Microbiome Composition Predictive of Patient Response to Statins - Business Wire - May 15th, 2022
- Finding A Place In Science - Texas A&M Today - Texas A&M University Today - May 15th, 2022